Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    16052573 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Low-dose Glucocorticoid Vasculitis Induction Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Drug: Rituximab;   Drug: Glucocorticoids
2 Not yet recruiting Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Condition: Granulomatosis With Polyangiitis (Wegener's Granulomatosis)
Interventions: Drug: Rituximab;   Other: Placebo
3 Active, not recruiting Rituximab Vasculitis Maintenance Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Biological: Rituximab;   Drug: Azathioprine

Study has passed its completion date and status has not been verified in more than two years.